improvement of bone mineral density with menaq7 360 mcg: a case report

Postpartum bone loss is a well-documented phenomenon, particularly in women with multiple pregnancies, as increased calcium demands during pregnancy and lactation can lead to transient reductions in bone mineral density. this case report describes a 35-year-old female with postpartum bone density reduction and degenerative joint changes who achieved significant improvement in bone mineral density (bmd) after 14 months of daily supplementation with menaq7 (vitamin k2 as mk-7, 360 mcg), trucal (700 mg calcium with essential minerals), and vitamin d3 (2000 iu). initially diagnosed with decreased bmd (t-score -1.8 at the left femoral neck, 76% of expected for age) and lumbar spine t-score of -0.9 (90%), the patient showed marked improvement, with scores increasing to -0.7 (90%) and 0.1 (101%), respectively. the observed benefits are likely due to menaq7's role in activating osteocalcin, optimizing calcium deposition in bones. additionally, matrix gla-protein (mgp) reduces calcifications in soft tissue. this case suggests that targeted supplementation may play a role in enhancing postpartum bone health and mitigating osteoporosis risk.